RGLS - What's Going On With Regulus Therapeutics Stock Monday? | Benzinga
Regulus Therapeutics, Inc. (NASDAQ:RGLS) shares were initially trading higher Monday before pulling back and turning negative after the company announced topline results from its study related to the treatment of autosomal dominant polycystic kidney disease (AKPD).
What Happened: The results from the Phase 1B MAD clinical trial ...